IN – AND OUT-OF COMPETITION Use of International Non-proprietary Names (INN) With the assistance of the World Health Organisation, the nomenclature of some substances on the List has been updated to International Non-proprietary Names (INN). For ease, however, previous names have been maintained and no substance has been deleted.
S1. Anabolic Agents To ensure clarification and accuracy, changes were made to the definitions of “exogenous” and “endogenous”
S2. Peptide Hormones, Growth Factors and Related Substances As made clear through points S2.2, S2.3 and S2.4, Releasing factors are prohibited. Furthermore, other prohibited growth factors are listed separately.
S5. Diuretics and other Masking Agents Vasopressing V2 antagonists (vaptans) were added as an example of a diuretic subclass.
M1. Manipulation of Blood and Blood Components For the purpose of scientific accuracy, the term allogenic was introduced.
IN-COMPETITION S6. Stimulants Some drugs that metabolize to amphetamine or methamphetamine have been reclassified because improved analytical techniques permit the identification of the administered drug and corresponding metabolites; MDMA and MDA are reclassified because they are now recognized as less likely to be used as doping agents; cathinone and its analogues (e.g. mephedrone, methedrone, a- pyrrolidinovalerophenone) and trimetazidine have been added as examples to reflect emerging patterns of drug use.
IN PARTICULAR SPORTS P1. Alcohol In the interest of accuracy, changes were made to the wording describing the blood alcohol threshold. In addition, “Aeronautic” has been replaced by “Air Sports”, and “FITA” has been replaced by its new acronym “WA” (World Archery).
P2. Beta-blockers “FITA” has been replaced by its new acronym “WA” (World Archery).
Monitoring Program In order to detect potential patterns of abuse, mitragynine has been added to the Narcotics class of the Monitoring Program.
For more information, please contact: email@example.com
To consult the 2014 Prohibited List, the 2014 Monitoring Program, a summary of modifications on the 2014 List, and a Q&A on any changes, please click here